Vimarsana
Biggest News Aggregation in the World

Page 3 - Triage Test News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Triage Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Triage Test Today - Breaking & Trending Today

SQI Diagnostics Reports First Quarter 2022 Results - Vimarsana News

SQI Diagnostics Reports First Quarter 2022 Results

/PRNewswire/ - SQI Diagnostics Inc. (TSXV: SQD) ( OTCQB: SQIDF), a leader in the science of lung health that develops and manufactures respiratory health and...

SQI Diagnostics Reports Fourth Quarter and Fiscal 2021 Results - Vimarsana News

SQI Diagnostics Reports Fourth Quarter and Fiscal 2021 Results

/PRNewswire/ - SQI Diagnostics Inc. ('SQI" or the "Company") (TSXV: SQD) (OTCQB: SQIDF), a leader in the science of lung health that develops and manufactures...

SQI Diagnostics Reports Fourth Quarter and Fiscal 2021 Results - Vimarsana News

SQI Diagnostics Reports Fourth Quarter and Fiscal 2021 Results

/PRNewswire/ - SQI Diagnostics Inc. ('SQI" or the "Company") (TSXV: SQD) (OTCQB: SQIDF), a leader in the science of lung health that develops and manufactures...

SQI Diagnostics Inc. Announces Grant of Stock Options - Vimarsana News

SQI Diagnostics Inc. Announces Grant of Stock Options

/PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSXV: SQD) (OTCQB: SQIDF), a life sciences and diagnostics company that develops and...

SQI Diagnostics Submits RALI-Dx; IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization - Vimarsana News

SQI Diagnostics Submits RALI-Dx; IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization

with Confirmed COVID-19 Illness TORONTO, April 1, 2021 /PRNewswire/ - SQI Diagnostics Inc. (the "Company" or "SQI") (TSXV: SQD) (OTCQB: SQIDF), a precision medicine company that discovers, develops and commercializes innovative rapid diagnostic testing for healthcare professionals, patients and consumers worldwide, announces that it has submitted its fully completed clinical and analytical data package to the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA) of its RALI-Dx ™ IL-6 Severity Triage Test. The submission was completed on March 31, 2021. The FDA wi...